
Specialty
Certifications
Nephrology
American Board of Internal Medicine
Clinical Focus
Education
DO, University of Kansas
Residency, Internal Medicine
Cleveland Clinic FoundationFellowship, Nephrology
Cleveland Clinic Foundation
Biography
Dr. Olin is a Professor of Medicine at Mount Sinai School of Medicine and Director of Vascular Medicine and the Vascular Diagnostic Laboratory in the Zena and Michael A. Wiener Cardiovascular Institute and Marie-Josée and Henry R. Kravis Center for Cardiovascular Health of The Mount Sinai Medical Center.
His clinical expertise involves noncoronary vascular diseases such as fibromuscular dysplasia, peripheral artery disease, carotid artery disease, renal artery disease, venous thromboembolic disease and less common peripheral vascular disease. He is an international leader in vascular ultrasound and has developed new noninvasive techniques to evaluate patients for renal artery stenosis and treat catheter associated pseudoaneurysms.
Dr. Olin is an internationally recognized expert in the area of Vascular Medicine. He has held numerous leadership positions and has been at the forefront of establishing Vascular Medicine as a distinct subspecialty of Cardiovascular Medicine. He was instrumental in the formation of the American Board of Vascular Medicine, the first ever board examination in this specialty. Dr. Olin is a past president of the Society for Vascular Medicine and recently has been awarded the highest honor from that society, Master of the Society for Vascular Medicine.
He is a past member of the peripheral vascular disease committee of the American College of Cardiology and past Chair of the Interdisciplinary Working Group on Atherosclerotic Peripheral Vascular Disease of the American Heart Association. He played an instrumental role in the transformation of this working group to that of a Council of the American Heart Association. He was a member of the highest-ranking scientific committee of the American Heart Association, the Scientific Advisory and Coordinating Committee. He is a member of the Board of Directors of the American Board of Vascular Medicine and is one of four physicians selected to direct a task force leading to an examination in the certification entitled Registered Physician in Vascular Ultrasound (RPVI).
Dr. Olin has been involved in clinical research involving fibromuscular dysplasia, peripheral artery disease, renal artery disease and carotid artery disease. He along with John Cooke, M.D., Ph.D. at Stanford University conducted the largest NIH study on the Genetics of Peripheral Arterial Disease. He is the Mount Sinai Principle Investigator of the NIH sponsored CORAL trial studying the effect of stents in patients with atherosclerotic renal artery stenosis. Dr. Olin was the international Principal Investigator and Chair of the Steering Committee for a study of Immune Modulation Therapy for patients with Peripheral Arterial Disease. He is the current U.S. Principal Investigator for the WALK trial investigating the role of gene therapy to grow new blood vessels in patients with peripheral arterial disease and has been active in gene therapy trials to prevent amputation in those patients with circulatory problems of the legs.
Dr. Olin has authored more than 180 scientific papers in the peer review literature, 3 books and more than 60 book chapters. He has served on many writing committees of the American College of Cardiology and American Heart Association. He currently is Chairing the writing committee on Performance Measures in Peripheral Arterial Disease, and the Scientific Statement from the American Heart Association on fibromuscular dysplasia. He has published in the New England Journal of Medicine, Circulation, Journal of the American Medical Association, Journal of the American College of Cardiology, Journal of Vascular Surgery and Vascular Medicine just to name a few. He is an Associate Editor of the journal Vascular Medicine and Editor of the textbook Peripheral Vascular Diseases.
After receiving his medical degree from the University of Health Sciences in Kansas City, Missouri, he completed his residency and fellowship at the Cleveland Clinic Foundation. In 2003 he came to the Mount Sinai School of Medicine as Director of Vascular Medicine and Co-director of the Vascular Diagnostic Laboratory where he has developed a comprehensive clinical, educational and research program in Vascular Medicine.
In The News: Dr. Jeffrey Olin discusses fibromuscular dysplasia in the The Daily News feature The Daily Check-Up.
Awards
-
New award
-
Associate Editor
Vascular Medicine2010 -
Steering Committee
2010 -
Chair American Heart Association Scientific Statement
2008 -
Master of the Society for Vascular Medicine
2008 - 2010
Chair Writing Committee
American College of Cardiology2005 - 2007
Chair
Interdisciplinary Working Group on Atherosclerotic Peripheral Vascular Disease of the American Heart Association2004 -
Present Chair
2002 - Present
Peripheral Vascular Disease Steering Committee of the American Heart Association
2000 - 2005
Scientific Program Committee
American College of Cardiology1991 -
Fellow
Society of Vascular Medicine and Biology1991 -
Fellow
American College of Cardiology1990 - 2001
President
Society for Vascular Medicine and Biology1987 -
Fellow
American College of Physicians1983 - 1984
Outstanding Teacher Award
Department of Medicine the Western Pennsylvania Hospital
Publications
Olin JW. Thromboangiitis Obliterans (Buerger's Disease). N Engl J Med 2000; 343: 864-869.
Slovut DP, Olin JW. Fibromuscular Dysplasia. N Engl J Med 2004; 350: 1862-71.
Olin JW. Current Treatme. Managed Care 2000; 9: 11-14.
Begelman S, Olin JW, Gray BH. Non-atherosclerotic arterial disease of the extracranial cerebrovasculature. Semin Vasc Surg 2000; 13: 153-164.
Olin JW. Society for Vascular Medicine and Biology Presidential Address. A vision for the . Vasc Med 2000; 5: 205-207.
Massullo-LaPerna L, Olin JW, Goines D, Ouriel K. Ultrasound guided thrombin injection for the. Circulation 2000; 102: 2391-5.
Hiatt WR, Regensteiner JG, Creager MA, Hirsch AT, Cooke JP, Olin JW, Gorbunov GN, Isner J, Lukjanov YV, Tsitsiashvili MS, Zabelskaya TF, Amato A. Propionyl-L-carnitine improves exercise performance and functional status in patients with claudication. Am J Med 2001; 1(110): 616-622.
Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, Olin JW, Krook SH, Hunninghake DB, Comerota AJ, Walsh ME, McDermott MM, Hiatt WR. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001; 286: 1317-1324.
Olin JW. Society for Vascular Medicine and Biology Presidential Address. Is vascular medicine a viable specialty?. Vasc Med 2001; 6: 129-131.
Ouriel K, Hertzer NR, Beven EG, O'Hara PJ, Krajewski LP, Clair DG, Greenberg RK, Sarac TP, Sarac TP, Olin JW, Yadav JS. Preprocedural risk stratification: Identifying an appropriate population for carotid stenting. J Vasc Surg 2001; 33: 728-732.
Clinical Trials
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Olin during 2012 and/or 2013. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Scientific Advisory Board:
- Novartis; Pluristem Therapeutics Inc.
Other Activities: Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership.
- AstraZeneca; Pluristem Therapeutics Inc.
Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)
- Northwind Medical
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.
Faculty Practice Associates Floor 3
5 East 98th Street
New York, NY 10029
5 East 98th Street, 3rd Floor
New York, NY 10029
Fax: 212-241-5107


- Monday
- Tuesday
- Wednesday 9:00am - 6:00pm
- Thursday
- Friday 8:00am - 12:30pm
- Spanish
- Aetna U.S. Healthcare
- Beech Street
- CarePlus, LLC
- CenterCare, Inc.
- Cigna
- Devon Health Services
- Empire Blue Cross/Blue Shield
- Fidelis Care NY
- First Health
- Group Health Insurance, Inc.
- Health Insurance Plan (HIP)
- Healthfirst
- Island Group
- Local 1199
- Magnacare
- Medicaid
- Medicaid New Jersey
- Medicare
- MetroPlus Health Plan
- MultiPlan, Inc.
- Neighborhood Health Providers, LLC
- Oxford Health Plans
- PHS/Healthnet/Guardian
- Pomco
- Private Healthcare Systems (PHCS)
- Travel Care Services
- United Health Care Empire Plan
- United Healthcare
- Master Card
- Visa
- Personal Check
- Cash


